BF activates PPAR-PGC1α signaling and mitochondrial biogenesis in brain, ameliorating Huntington’s disease, mitochondrial encephalopathy and tau pathology phenotypes in mice [30–32]. This evidence concerns the gene PPARGC1A and Mitochondrial encephalopathy.